European Cardiovascular Biomaterials Market Research Report
- Report Code: CA 1002
- Publish Date: Upcoming
“The European Cardiovascular Biomaterials market forecast 2012-2018”
The European Cardiovascular Biomaterials market has seen challenging and dynamic market conditions. The European Cardiovascular Biomaterials market, mainly driven by Increased Investments, Funds, And Grants By Government Bodies Worldwide, Precipitous Growth Anticipated For Plastic Surgery And Wound Healing Applications , Growing Number Of Elderly People , Technological Advancements and Changing Lifestyles .
The report “The European Cardiovascular Biomaterials market forecast 2012-2018” analyzes the market by technology devices into 8 segments such as Catheters, Guide wires, Sensor, Pacemaker, Implantable Cardiac Defibrillators, Vascular Grafts, Heart Valves and Stents.
Increased investments, funding and grants by government bodies worldwide, incessant rise in the number of collaborations, conferences and research-related activities, technological advancements, increasing applications of biomaterials, and growing number of elderly people are the major factors propelling the growth of the Cardiovascular biomaterial market in Europe. Immunological and inflammatory reactions, stringent regulatory systems, issue of fatigue and wear and reimbursement concerns are the major deterrents curbing the cardiovascular biomaterial market.
The European Cardiovascular biomaterial market witnesses a plethora of growth opportunities. Biomaterials extensively used for cardiovascular applications include metals such as titanium, stainless steel, and cobalt-chrome alloy and processed biological substances such as collagen and gelatin. These injectables also help in treating cardiac disorders.
Novel developments of biomaterial for wound healing, tissue engineering, colossal pool of cardiac patients in Europe, rise of Cardiovascular biomaterial market in Germany and increased conferences and research-related activities in European countries are major factors influencing the growth of the Cardiovascular biomaterial market. The burning issues affecting the growth of cardiovascular biomaterial market are challenges to tissue engineering and effect on suppliers by the Biomaterials Access Assurance Act.
The European Cardiovascular biomaterial market is dominated by Europe. European market growth is likely to be driven by increasing government investments in biomaterial sector, reimbursements offered by Centers for Medicare and Medicaid Services (CMS) and rising aging population who are the main consumers of Cardiovascular biomaterials.
Some of the key players in The European Cardiovascular Biomaterials market include Medtronic, Inc., Biomet, Inc., Stryker Corporation, Synthes, Inc. and others. The segment and country-specific company shares, news & deals, M&A, segment specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report.
Customization Options:
Along with the market data, you can also customize the MMM assessments to meet your company’s specific needs. Customize to get a comprehensive summary of the industry standards and a deep dive analysis of the following parameters:
Product Analysis:
- Usage pattern (in-depth trend analysis) of products (segment-wise)
- Product matrix, which gives a detailed comparison of product portfolio of each company, mapped at country and sub-segment levels
- End-user adoption rate analysis of the products (segment-wise and country-wise)
- A comprehensive coverage of product approvals, pipeline products and product recalls
Epidemiology Data
- Country-specific prevalence of Cardiaovascular applications of Biomaterials
- Country-specific patient pool of Cardiaovascular applications of Biomaterials (pattern analysis)
Procedure Volume Data
- Biomaterials used in Cardiaovascular procedures performed annually in each country, tracked till sub-segment level
- The number of Cardiaovascular procedures performed in each country
Surgeons/Physicians Perception Analysis:
- Fast turn-around analysis of surgeons’ responses to market events and trends
- Pattern analysis of usage of Biomaterials by physicians
- Surgeons’ opinions about products from different companies
- Surgeons’ qualitative inputs on Plastic Surgery data
Brand/Product Perception Matrix:
- A comprehensive study of customers’ perception and behavior through our inbuilt social connect tool checking the virality and tonality of blogs
- Analysis of overall brand usage and familiarity and brand advocacy distribution (Detractor/Neutral/Familiar)
Alternative Products: Impact analysis
MMM’s Healthcare Decision Making Quadrant: It is an innovative and useful quadrant for vendors who wish to analyze the potential growth markets based on parameters like patient dynamics (patient pool, epidemiology of disease, preference towards surgeries/alternative therapies) and macroeconomic indicators (number of hospitals and orthopedic clinics, reimbursement scenario, diagnosis rate, treatment rate and healthcare expenditure)
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
|
|
North American Biomaterials Market The report “The North American Biomaterials market forecast 2012-2014” analyzes the market by technology devices into 4 segments such as Metals, Ceramics, Polymers and Natural Biomaterial. Some of the key players in The North American Biomaterials market include Medtronic, Inc., Biomet, Inc., Stryker Corporation, Synthes, Inc. and others. The segment and country-specific company shares, news & deals, M&A, segment specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report. |
Upcoming |
|
|
European Biomaterials Market The report “The European Biomaterials market forecast 2012-2014” analyzes the market by technology devices into 4 segments such as Metals, Ceramics, Polymers and Natural Biomaterial. Some of the key players in The European Biomaterials market include Medtronic, Inc., Biomet, Inc., Stryker Corporation, Synthes, Inc. and others. The segment and country-specific company shares, news & deals, M&A, segment specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report. |
Upcoming |
|
|
Asian Biomaterials Market The report “The Asian Biomaterials market forecast 2012-2014” analyzes the market by technology devices into 4 segments such as Metals, Ceramics, Polymers and Natural Biomaterial. Some of the key players in The Asian Biomaterials market include Medtronic, Inc., Biomet, Inc., Stryker Corporation, Synthes, Inc. and others. The segment and country-specific company shares, news & deals, M&A, segment specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report. |
Upcoming |
